Tekmira Pharmaceuticals (TKMR:NASDAQ) (TKM:TSX) has joined an International Consortium to conduct clinical trials of the Ebola Virus Therapeutics spreading throughout West Africa.

The biotech stock has been on fire in recent months as the Ebola virus spreads and Tekmira works to provide a solution.

The company announced this morning that the Consortium has received £3.2 million funding from Wellcome Trust.